Literature DB >> 15081892

Ubiquitin expression is up-regulated in human and rat skeletal muscles during aging.

Dongqing Cai1, K K H Lee, M Li, M K Tang, K M Chan.   

Abstract

In this study, we have used two-dimensional electrophoresis, protein sequencing, immunoblotting, and immunohistochemistry to identify proteins that were differentially expressed during aging in human and rat skeletal muscles. Ubiquitin was identified. It was expressed at high levels in old fast-twitch muscles but at low levels in young fast-twitch muscles. It was also discovered that exogenous ubiquitin could suppress the growth of C2C12 cells, in vitro. The reduction in C2C12 cell growth was not attributed to an increase in apoptosis but to an inhibition in cell cycle entry. Furthermore, it was possible to induce muscles to degenerate in vivo by injecting a high dose of exogenous ubiquitin into young healthy skeletal muscles. These results suggest that hyperactivity of the ubiquitin-proteasome pathway is involved in the aging process of fast-twitch muscles. In addition, ubiquitin-dependent growth suppression in satellite cells may be associated with the poor healing potential of old skeletal muscles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081892     DOI: 10.1016/j.abb.2004.02.027

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  23 in total

Review 1.  Psychological stress and aging: role of glucocorticoids (GCs).

Authors:  K M Mehedi Hasan; Md Shaifur Rahman; K M T Arif; Mahbub E Sobhani
Journal:  Age (Dordr)       Date:  2011-10-05

Review 2.  Beneficial effects of exercise on age-related mitochondrial dysfunction and oxidative stress in skeletal muscle.

Authors:  Anna-Maria Joseph; Peter J Adhihetty; Christiaan Leeuwenburgh
Journal:  J Physiol       Date:  2015-11-21       Impact factor: 5.182

3.  Effects of ageing on expression of the muscle-specific E3 ubiquitin ligases and Akt-dependent regulation of Foxo transcription factors in skeletal muscle.

Authors:  Akira Wagatsuma; Masataka Shiozuka; Yuzo Takayama; Takayuki Hoshino; Kunihiko Mabuchi; Ryoichi Matsuda
Journal:  Mol Cell Biochem       Date:  2015-11-20       Impact factor: 3.396

4.  The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions.

Authors:  Vikas Saini; Daniel M Staren; Joshua J Ziarek; Zayd N Nashaat; Edward M Campbell; Brian F Volkman; Adriano Marchese; Matthias Majetschak
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

Review 5.  Aging and regulated protein degradation: who has the UPPer hand?

Authors:  Vita A Vernace; Thomas Schmidt-Glenewinkel; Maria E Figueiredo-Pereira
Journal:  Aging Cell       Date:  2007-08-06       Impact factor: 9.304

6.  Proteolysis activation and proteome alterations in murine skeletal muscle submitted to 1 week of hindlimb suspension.

Authors:  Rita Ferreira; Rui Vitorino; Maria João Neuparth; Hans-Joachim Appell; José Alberto Duarte; Francisco Amado
Journal:  Eur J Appl Physiol       Date:  2009-08-19       Impact factor: 3.078

Review 7.  Atrogin-1, MuRF-1, and sarcopenia.

Authors:  Jonathan P Gumucio; Christopher L Mendias
Journal:  Endocrine       Date:  2012-07-20       Impact factor: 3.633

8.  Chronic hypobaric hypoxia mediated skeletal muscle atrophy: role of ubiquitin-proteasome pathway and calpains.

Authors:  Pooja Chaudhary; Geetha Suryakumar; Rajendra Prasad; Som Nath Singh; Shakir Ali; Govindsamy Ilavazhagan
Journal:  Mol Cell Biochem       Date:  2012-01-04       Impact factor: 3.396

Review 9.  Mitochondria Initiate and Regulate Sarcopenia.

Authors:  Stephen E Alway; Junaith S Mohamed; Matthew J Myers
Journal:  Exerc Sport Sci Rev       Date:  2017-04       Impact factor: 6.230

10.  Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists.

Authors:  Jonathan M Eby; Hazem Abdelkarim; Lauren J Albee; Abhishek Tripathi; Xianlong Gao; Brian F Volkman; Vadim Gaponenko; Matthias Majetschak
Journal:  Mol Cell Biochem       Date:  2017-04-28       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.